Synapse - Works

Results (86)

Genetic profiling analysis design of well-differentiated aggressive grade 2 and 3 gastroenteropancreatic neuroendocrine tumors in the phase III randomized controlled COMPOSE trial

Meeting Abstract

Halfdanarson, T. R.; Capdevila, J.; Halperin, D. M.; Herrmann, K.; Kong, G.; Leyden, S.; Mailman, J.; Reidy-Lagunes, D.; Srirajaskanthan, R.; Erdö, M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)

Meeting Abstract

Cowzer, D.; Shah, R. H.; Punn, S.; Fiedler, L.; DeMore, A.; Chou, J. F.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; Raj, N. P.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors: Final analysis of efficacy and evaluation of MGMT (ECOG-ACRIN E2211)

Meeting Abstract

Kunz, P. L.; Graham, N.; Catalano, P. J.; Nimeiri, H.; Fisher, G. A.; Longacre, T. A.; Suarez, C. J.; Rubin, D.; Yao, J. C.; Kulke, M. H.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

The frequency of second primary malignancies and colonic polyps in Lynch syndrome with MSI tumors following immune checkpoint blockade

Meeting Abstract

Harrold, E.; Patel, Z.; Maio, A.; Cercek, A.; Yaeger, R.; Segal, N. H.; Reidy, D. L.; O'Reilly, E. M.; Desai, A. M.; Carlo, M. I.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Association between remote monitoring and acute care visits in high-risk patients initiating intravenous antineoplastic therapy

Meeting Abstract

Daly, R. M.; Nicholas, K.; Flynn, J.; Panageas, K.; Silva, N.; Duck, E.; Zervoudakis, A.; Holland, J. C.; Salvaggio, R.; Begue, A.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Early-onset well differentiated pancreatic neuroendocrine tumors: Clinical presentation, pathologic features, and oncological outcomes

Meeting Abstract

Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C. A.; Reidy, D. L.; Wei, A. C. C.; Raj, N. P.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Treatment response and clinical outcomes of neuroendocrine neoplasms treated with immune checkpoint inhibitors: A single-institution experience

Meeting Abstract

Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy, D. L.; Raj, N. P.
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Pivotal phase III COMPOSE trial will compare (177)Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors

Meeting Abstract

Halfdanarson, T. R.; Reidy, D. L.; Vijayvergia, N.; Halperin, D. M.; Goldstein, G.; Kong, G.; Michael, M.; Leyden, S.; Grozinsky-Glasberg, S.; Sorbye, H.; more...
Journal of Clinical Oncology (2022)

Fulltext@MSK | Save

Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part B (pembrolizumab plus chemotherapy)

Meeting Abstract

Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Calabrese, S.; DeMore, A.; Dhawan, M. S.; Fattah, D.; Fong, L.; Grabowsky, J.; Hope, T. A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Use of remote patient monitoring in the care of COVID-positive patients in oncology

Meeting Abstract

Pugliese, L.; Garcia, J.; Holland, J. C.; Majeed, J.; Silverman, M.; Moy, M.; Kemeny, E.; Reidy, D. L.; Robson, M. E.; Connor, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save